The 4 breast cancer patients had P/LP variants in BRCA1 (with ovarian cancer and thyroid cancer), BRCA2 (with endometrial cancer), BRCA2 (with thyroid cancer) and TP53 (with brain tumor). This evidence concerns the gene BRCA1 and breast cancer.